Dec 29, 2014
Farmak brought Keywer, an anaesthetic and anti-inflammatory medicine, to the market
Farmak, a domestic leader of the pharmaceutical market, continues extending the portfolio of anti-inflammatory and anaesthetic products. Thus, a new product, Keywer, solution for injection 50 mg/ml 2 ml No 10 and tablets 25 mg No 10 is introduced to the market.
Keywer, solution for injection, is recommended for:
- Symptomatic treatment of acute moderate and severe pain when oral administration is unreasonable, for instance, postoperative pain, renal colic and pain in the small of the back.
Keywer, tablets, is recommended for:
- Symptomatic therapy of mild and moderate pain, for instance, musculoskeletal pain, dysmenorrhea, toothache.
